These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 29742944)

  • 21. A case of mucinous cholangiocarcinoma showing features of hepatocellular carcinoma.
    Kai K; Ide Y; Miyoshi A; Masuda M; Ide T; Kitahara K; Irie H; Nakajima J; Noshiro H; Tokunaga O
    Pathol Int; 2013 Aug; 63(8):419-21. PubMed ID: 23957918
    [No Abstract]   [Full Text] [Related]  

  • 22. Intraperitoneal rupture of cholangiocarcinoma in a patient with liver cirrhosis, type C, with hepatocellular carcinoma.
    Watanabe M; Akagi S; Hamamoto S
    Am J Gastroenterol; 1999 Aug; 94(8):2320-1. PubMed ID: 10445582
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for alpha-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma.
    Okuda H; Shiratori K; Yamamoto M; Takasaki K; Nakano M
    J Gastroenterol Hepatol; 2006 May; 21(5):869-73. PubMed ID: 16704538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mimics of cholangiocarcinoma: spectrum of disease.
    Menias CO; Surabhi VR; Prasad SR; Wang HL; Narra VR; Chintapalli KN
    Radiographics; 2008; 28(4):1115-29. PubMed ID: 18635632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathology of combined hepatocellular-cholangiocarcinoma.
    Yeh MM
    J Gastroenterol Hepatol; 2010 Sep; 25(9):1485-92. PubMed ID: 20796144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential diagnosis of malignant epithelial tumours in the liver: an immunohistochemical study on liver biopsy material.
    Al-Muhannadi N; Ansari N; Brahmi U; Satir AA
    Ann Hepatol; 2011; 10(4):508-15. PubMed ID: 21911893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pan-viral serology uncovers distinct virome patterns as risk predictors of hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Do WL; Wang L; Forgues M; Liu J; Rabibhadana S; Pupacdi B; Zhao Y; Gholian H; Bhudhisawasdi V; Pairojkul C; Sukeepaisarnjaroen W; Pugkhem A; Luvira V; Lertprasertsuke N; Chotirosniramit A; Auewarakul CU; Ungtrakul T; Sricharunrat T; Sangrajrang S; Phornphutkul K; Budhu A; Harris CC; Mahidol C; Ruchirawat M; Wang XW
    Cell Rep Med; 2023 Dec; 4(12):101328. PubMed ID: 38118412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of incidental/misdiagnosed intrahepatic cholangiocarcinoma and combined hepatocellular cholangiocarcinoma on the outcomes of liver transplantation: an institutional case series and literature review.
    Gupta R; Togashi J; Akamatsu N; Sakamoto Y; Kokudo N
    Surg Today; 2017 Aug; 47(8):908-917. PubMed ID: 28124125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hepatocellular carcinoma and cholangiocarcinoma].
    Rauchfuss F; Scheuerlein H; Götz M; Dittmar Y; Voigt R; Heise M; Settmacher U
    Chirurg; 2010 Oct; 81(10):941-52; quiz 953. PubMed ID: 20827454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distal common bile duct metastasis from hepatocellular carcinoma.
    Kim YC; Park MS
    Hepatology; 2012 May; 55(5):1638-9. PubMed ID: 22121016
    [No Abstract]   [Full Text] [Related]  

  • 31. Association of nonalcoholic fatty liver disease and liver cancer.
    Schulz PO; Ferreira FG; Nascimento Mde F; Vieira A; Ribeiro MA; David AI; Szutan LA
    World J Gastroenterol; 2015 Jan; 21(3):913-8. PubMed ID: 25624725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of AFP-producing cholangiocarcinoma with difficulty in differential diagnosis from hepatocellular carcinoma].
    Omori J; Niimi A; Furuichi Y; Takeuchi E; Ishikawa T; Yanagisawa A; Ogihara S; Tsuchiya M; Misaka R; Shigemoto M; Kurihara T; Maeda A; Yamashita K; Aratake T; Kameoka S; Nishikawa T
    Nihon Shokakibyo Gakkai Zasshi; 2004 Oct; 101(10):1106-11. PubMed ID: 15529784
    [No Abstract]   [Full Text] [Related]  

  • 33. Combined hepatocellular-cholangiocarcinoma and its mimickers: Diagnostic pitfalls in surgical pathology.
    Laohawetwanit T; Lerttanatum N; Wanpiyarat N; Manasilp N; Chaiparnich S
    Ann Diagn Pathol; 2021 Aug; 53():151770. PubMed ID: 34147845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longterm prognosis of combined hepatocellular carcinoma-cholangiocarcinoma following liver transplantation and resection.
    Jung DH; Hwang S; Song GW; Ahn CS; Moon DB; Kim KH; Ha TY; Park GC; Hong SM; Kim WJ; Kang WH; Kim SH; Yu ES; Lee SG
    Liver Transpl; 2017 Mar; 23(3):330-341. PubMed ID: 28027599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The value of CA19-9 in diagnosing hepatocellular carcinoma and intrahepatic cholangiocarcinoma].
    Chen Y; Wang ZM; Ren ZG; Le F; Zhang BH; Xia JL; Ye SL; Tang ZY
    Zhonghua Gan Zang Bing Za Zhi; 2006 Apr; 14(4):299-300. PubMed ID: 16635306
    [No Abstract]   [Full Text] [Related]  

  • 36. Intrahepatic cholangiocarcinoma: Tumour heterogeneity and its clinical relevance.
    Komuta M
    Clin Mol Hepatol; 2022 Jul; 28(3):396-407. PubMed ID: 35032970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma.
    European Association for the Study of the Liver
    J Hepatol; 2023 Jul; 79(1):181-208. PubMed ID: 37084797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrahepatic cholangiocarcinoma diagnosed preoperatively as hepatocellular carcinoma.
    Yamamoto M; Ariizumi S; Otsubo T; Katsuragawa H; Katagiri S; Nakano M; Takasaki K
    J Surg Oncol; 2004 Aug; 87(2):80-3; discussion 83-4. PubMed ID: 15282700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraductal Hepatocellular Carcinoma without Parenchymal Tumor: A Case Report.
    Ramakrishna B; Shah GJ; Vyas F
    J Gastrointest Cancer; 2012 Sep; 43 Suppl 1():S77-9. PubMed ID: 21814761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrahepatic cholangiocarcinoma biomarkers: Towards early detection and personalized pharmacological treatments.
    Capuozzo M; Santorsola M; Ferrara F; Cinque C; Farace S; Patrone R; Granata V; Zovi A; Nasti G; Ottaiano A
    Mol Cell Probes; 2024 Feb; 73():101951. PubMed ID: 38244704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.